[Lysozyme content in biological substrates and immunological indices of the blood in pneumonia patients].
An increase of lysozyme content in biological fluids observed during treatment of pulmonary diseases was shown to be followed by positive immunological and clinical effects. The parameters of immunological properties of lysozyme determined on the patient blood cells in vitro (before treatment) may be used for prediction of the drug efficacy during treatment.
Ponomareva
A G
AG
Tsarev
V N
VN
Medvedev
V M
VM
Fomicheva
E M
EM
D000276:Adjuvants, Immunologic; D001826:Body Fluids / Q000187:drug effects / Q000201:enzymology*; D001996:Bronchopneumonia / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D009113:Muramidase / Q000032:analysis* / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy / Q000201:enzymology* / Q000276:immunology
D000276:Adjuvants, Immunologic; D009113:Muramidase
Soderzhanie lizotsima v biologicheskikh substratakh i immunologicheskie pokazateli krovi bol'nykh pnevmonieĭ.